Our ORA bioinformatic analysis provides putative tumor promoting pathways to investigate that would be acquired during chronic IL-1 exposure, such as insulin and interferon gamma signaling, glucose homeostasis and metabolism and cell adhesion. Here, IL1A is linked to neoplasm.